Senior insider sale
Chief Executive Officer at AXSOME THERAPEUTICS, INC. — senior position signals high conviction
$23.92M
99.34K shares
What this filing means
TABUTEAU HERRIOT plans to sell 99.34K shares of AXSOME THERAPEUTICS, INC. valued at approximately $23.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001958244-26-000417
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
99.34K
Shares to sell
$23.92M
Approx. market value
49.67K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Acquired as compensation -- Stock Options
Compensation -- Cashless exercise / same-day sale
3/15/2017
49.67KTotal acquired49.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2017 | Acquired as compensation -- Stock Options Compensation -- Cashless exercise / same-day sale | 49.67K | — |
| Total | 49.67K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
24.84K
Market value
$5.95M
6/9/2026
—Completed
Units to sell
24.84K
Market value
$6.02M
6/9/2026
Planned — Approximate Date
NASDPlanned
Units to sell
49.67K
Market value
$11.95M
7/1/2026
Total
Units
99.34K
Value
$23.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/9/2026 | 24.84K | $5.95M | — | Completed |
6/9/2026 | 24.84K | $6.02M | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 49.67K | $11.95M | NASD | Planned |
| Total | 99.34K | $23.92M | ||